Cylerity is a technology company.
Cylerity has raised $4.0M across 1 funding round.
Cylerity has raised $4.0M in total across 1 funding round.
Cylerity has raised $4.0M in total across 1 funding round.
Cylerity's investors include C2Ventures, HealthX Ventures.
Cylerity is a fintech company headquartered in Madison, Wisconsin, specializing in healthcare financing solutions that address cash flow challenges for providers due to delayed insurance and Medicare reimbursements.[1][2] Its platform advances 70-90% of expected claim values within 48 hours using a proprietary algorithm to predict reimbursements, delays, and denial risks, targeting rural and critical access hospitals to provide lower-cost capital access previously unavailable to smaller providers.[1][2] With under 25 employees and revenue below $5 million, Cylerity recently raised a $4M seed round and secured up to $24M in debt facilities as of October 2025, signaling strong early growth momentum in stabilizing provider revenue without operational changes.[2]
Cylerity emerged from a team of diverse experts in banking, finance, healthcare billing, payments, supplies, and technology who identified a core challenge: helping healthcare leaders better access and manage financial resources amid complex reimbursement delays.[3] Founded in Madison, Wisconsin, the company developed its platform to deliver real-time financial insights and rapid advances on accounts receivable, starting with a focus on Medicare and commercial insurance claims.[1][2][3] Key early traction includes the October 2025 announcement of a $4M seed round and up to $24M debt facility, directly tackling the "slow pay problem" threatening rural hospitals' viability.[2]
Cylerity rides the fintech-healthcare convergence trend, addressing reimbursement delays that endanger rural hospitals amid rising closures and consolidations by larger systems.[2] Its timing aligns with intensifying pressures on U.S. healthcare financing, where slow insurance payments exacerbate cash flow volatility for smaller providers, a market force amplified by post-pandemic financial strains.[1][2] By collateralizing claims via AI-driven valuation, Cylerity influences the ecosystem by broadening affordable capital access, potentially stabilizing community hospitals and fostering innovation in accounts receivable (A/R) financing.[2][3]
Cylerity's platform positions it to scale rapidly with its recent $4M seed and $24M debt facility, likely expanding to more provider types and integrating deeper analytics for proactive financial management.[2][3] Trends like AI-enhanced risk modeling and regulatory pushes for rural healthcare sustainability will shape its growth, potentially evolving its influence toward a broader A/R financing standard in healthcare.[1][2] As adoption grows, Cylerity could redefine cash flow acceleration, empowering providers to prioritize patient care over financial survival.[2]
Cylerity has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2025 | $4.0M Seed | C2Ventures, HealthX Ventures |